Barclays’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-38
| Closed | – | – | 4431 |
|
|
2024
Q3 | $0 | Hold |
38
| – | – | ﹤0.01% | 4388 |
|
|
2024
Q2 | $0 | Hold |
38
| – | – | ﹤0.01% | 4266 |
|
|
2024
Q1 | $0 | Hold |
38
| – | – | ﹤0.01% | 4237 |
|
|
2023
Q4 | $0 | Sell |
38
-38
| -50% | – | ﹤0.01% | 4296 |
|
|
2023
Q3 | $0 | Buy |
76
+38
| +100% | – | ﹤0.01% | 4336 |
|
|
2023
Q2 | $0 | Sell |
38
-189,969
| -100% | – | ﹤0.01% | 4346 |
|
|
2023
Q1 | $134K | Buy |
190,007
+23,366
| +14% | +$16.5K | ﹤0.01% | 3375 |
|
|
2022
Q4 | $125K | Buy |
166,641
+127,171
| +322% | +$95.4K | ﹤0.01% | 3346 |
|
|
2022
Q3 | $34K | Buy |
39,470
+19,470
| +97% | +$16.8K | ﹤0.01% | 3770 |
|
|
2022
Q2 | $22K | Sell |
20,000
-406,085
| -95% | -$447K | ﹤0.01% | 4051 |
|
|
2022
Q1 | $477K | Buy |
426,085
+53,291
| +14% | +$59.7K | ﹤0.01% | 2841 |
|
|
2021
Q4 | $596K | Buy |
372,794
+352,794
| +1,764% | +$564K | ﹤0.01% | 2456 |
|
|
2021
Q3 | $48K | Hold |
20,000
| – | – | ﹤0.01% | 3399 |
|
|
2021
Q2 | $63K | Sell |
20,000
-58,988
| -75% | -$186K | ﹤0.01% | 3301 |
|
|
2021
Q1 | $266K | Buy |
+78,988
| New | +$266K | ﹤0.01% | 3007 |
|
|
2019
Q3 | – | Sell |
-8
| Closed | – | – | 4308 |
|
|
2019
Q2 | $0 | Buy |
+8
| New | – | ﹤0.01% | 4330 |
|